ZBH
Zimmer Biomet Holdings, Inc. · Healthcare · Medical Devices
TECHSellZACKSHold
R500#243 today
$88.29
+0.26% today · -2.77% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- ZBH +0.26% on the last session vs SPY +0.74%: −0.5 pts of stock-specific move.
- Aftermath, big drop (Sep 30): After its 61 big drops in the past 5 years, ZBH typically gained 0.8% over the next month (median) and was higher 52% of the time; half the outcomes fell between -4.6% and +6.5%. An ordinary month: -0.3%. Among S&P 500 stocks after big drops, that ranks #343 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 5
Before the open · in 32 days
EPS estimate
$1.88
$1.86 to $1.91 · 24 analysts
Revenue estimate
$2.0B
$2.0B to $2.1B
Track record
7/8 beats
last 8 reports · moved ±7.6% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 BMO | 2Q2026 | $2.01 | $2.07 | +$0.06 (+3.0%) beat | $2.2B | +2.5% +2.6 vs SPY | +5.4% | +1.5% |
| Apr 28, 2026 BMO | 1Q2026 | $1.86 | $2.09 | +$0.23 (+12.2%) beat | $2.1B | -10.6% -10.1 vs SPY | -5.4% | -10.7% |
| Feb 10, 2026 BMO | 4Q2025 | $2.40 | $2.42 | +$0.02 (+0.9%) beat | $2.2B | +1.9% +2.1 vs SPY | +4.9% | +8.3% |
| Nov 5, 2025 BMO | 3Q2025 | $1.87 | $1.90 | +$0.03 (+1.8%) beat | $2.0B | -15.2% -15.5 vs SPY | -12.1% | -14.2% |
| Aug 7, 2025 BMO | $1.98 | $2.07 | +$0.09 (+4.5%) beat | — | +8.0% +8.1 vs SPY | +5.2% | +13.2% | |
| May 5, 2025 BMO | $1.77 | $1.81 | +$0.04 (+2.3%) beat | — | -11.6% -11.1 vs SPY | -2.7% | -7.0% | |
| Feb 6, 2025 BMO | $2.29 | $2.31 | +$0.02 (+0.9%) beat | — | -5.1% -5.5 vs SPY | -3.9% | -8.6% | |
| Oct 30, 2024 BMO | $1.74 | $1.74 | $0.00 (0.0%) in line | — | +5.7% +6.0 vs SPY | +3.5% | +4.8% | |
| Aug 7, 2024 BMO | $1.99 | $2.01 | +$0.02 (+1.0%) beat | — | -3.4% -2.8 vs SPY | -2.6% | -0.2% | |
| May 2, 2024 BMO | $1.87 | $1.94 | +$0.07 (+3.7%) beat | — | -0.9% -1.9 vs SPY | +2.0% | +1.1% | |
| Feb 8, 2024 BMO | $2.16 | $2.20 | +$0.04 (+1.9%) beat | — | -3.5% -3.6 vs SPY | -5.4% | -4.5% | |
| Nov 7, 2023 BMO | $1.60 | $1.65 | +$0.05 (+3.1%) beat | — | -3.1% -3.4 vs SPY | -2.9% | -3.2% | |
| Aug 1, 2023 BMO | $1.81 | $1.82 | +$0.01 (+0.6%) beat | — | -4.3% -4.0 vs SPY | -5.1% | -9.1% | |
| May 2, 2023 BMO | $1.64 | $1.89 | +$0.25 (+15.2%) beat | — | +3.0% +4.1 vs SPY | +5.2% | -1.0% | |
| Feb 3, 2023 BMO | $1.83 | $1.88 | +$0.05 (+2.7%) beat | — | +1.6% +2.7 vs SPY | +0.2% | +0.7% | |
| Nov 2, 2022 BMO | $1.56 | $1.58 | +$0.02 (+1.3%) beat | — | -3.7% -1.2 vs SPY | +2.8% | -5.0% | |
| Aug 2, 2022 BMO | $1.64 | $1.82 | +$0.18 (+11.0%) beat | — | +3.9% +4.6 vs SPY | +3.0% | +3.1% | |
| May 3, 2022 BMO | $1.42 | $1.61 | +$0.19 (+13.4%) beat | — | 0.0% -0.4 vs SPY | +2.8% | -4.7% | |
| Feb 7, 2022 BMO | $1.98 | $1.95 | −$0.03 (−1.5%) miss | — | -9.1% -8.8 vs SPY | -6.9% | -5.4% | |
| Nov 4, 2021 BMO | $1.76 | $1.81 | +$0.05 (+2.8%) beat | — | -7.4% -7.9 vs SPY | -2.5% | -10.0% | |
| Aug 3, 2021 BMO | $1.86 | $1.90 | +$0.04 (+2.2%) beat | — | — | — | — | |
| May 4, 2021 BMO | $1.53 | $1.71 | +$0.18 (+11.8%) beat | — | — | — | — | |
| Feb 5, 2021 BMO | $2.06 | $2.11 | +$0.05 (+2.4%) beat | — | — | — | — | |
| Nov 6, 2020 BMO | $1.08 | $1.81 | +$0.73 (+67.6%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $1.88 (24) | $1.86 – $1.91 | -1% | +0.3% | ▲12 ▼7 | $2.0B | +2% |
| Next quarter · Dec 31, 2026 | $2.49 (24) | $2.43 – $2.54 | +3% | -0.6% | ▲4 ▼15 | $2.3B | +2% |
| Current year · Dec 31, 2026 | $8.53 (27) | $8.49 – $8.57 | +4% | +0.6% | ▲22 ▼1 | $8.6B | +4% |
| Next year · Dec 31, 2027 | $9.07 (27) | $8.77 – $9.58 | +6% | +0.9% | ▲19 ▼5 | $8.9B | +4% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.